BTNX Rapid Response Benzodiazepine Test Strips (Liquid/Powder) - 100 Tests

Product Information

• Product Code: BZO-18S3-100
• Quantity: 100 Tests / Kit
• Sample: Liquid / Powder
• Format: Strip
• Sensitivity: 300 ng/mL
• Specificity: Benzodiazepine
• Time-to-Result: Instant Results*
• Storage Condition: 36-86°F/2-30°C
• Test Principle: Lateral Flow Immunoassay

Contents

• Test strips
• Result interpretation card
• Product insert

 WARNING: THIS TEST DOES NOT EVALUATE DRUG SAFETY OR PURITY 

The Rapid Response™ Benzodiazepine Test Strip (Liquid / Powder) is a rapid visual immunoassay for the qualitative, presumptive detection of benzodiazepine in suspicious substances (liquids or powders) at the cut-off concentration of 300 ng/mL. Easy to use with detailed instructions for testing both liquid and powder samples. For forensic use only. Not an IVD.

References

1. Griffin III, C. E. et al. The Ochsner Journal 2013.
2. Schmitz, A. Ment Health Clin 2016.
3. United States Drug Enforcement Administration. Drug Fact Sheet: Benzodiazepines 2020.
4. Blakey, K. et al. Drug Test Anal 2021.
5. Jurásek, B. et al. Int J Clin Pract. 2020.
6. Tobias, S. et al. Drug Alc Dep 2020.
7. Centre on Drug Policy Evaluation. Toronto’s increasingly unpredictable and toxic unregulated opioid supply 2023.
8. Substance Abuse and Mental Health Services Administration. The TEDS Report: Admissions Reporting Benzodiazepine and Narcotic Pain Reliever Abuse at Treatment Entry 2012.
9. British Columbia Centre on Substance Use Drug Checking in British Columbia 2023.
10. Nation Library of Medicine Benzodiazepine Toxicity 2023.
11. Canadian Centre on Substance Use and Addiction Prescription Opioids (Canadian Drug Summary) 2022.

 

Disclaimers

* A negative result can be interpreted as soon as both the test (T) and control (C) lines appear. A positive result can be interpreted once the control line has appeared and the background has cleared to white, typically by 60 seconds. Do not read results after 10 minutes.

• The test device is NOT intended to determine the purity, composition, or if the substance being examined is safe to use.
• A positive or negative test result is NOT an indication that the substance being examined is safe to use. Many factors come into play when examining the samples, including but not limited to mixture of multiple substances, solubility, and pH of the sample.
• BTNX Inc. does not encourage the use, supply, or production of illegal drugs or controlled substances in any way. The device is intended for harm reduction purposes. Follow the advice of your local harm reduction or public health agency.
• There is a possibility that technical or procedural errors as well as other substances and factors may interfere with the Rapid Response™ Benzodiazepine Test Strip (Liquid / Powder) and cause false results.
• A positive result indicates the presence of benzodiazepine only and does not indicate quantity.
• A negative result does not at any time rule out the presence of benzodiazepine, as they may be present below the minimum detection level of the test.

• Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
• The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
• Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.